Akebia Therapeutics
AKBA
$2.57
Share price
-1.54%
Change (1 day)
-4.43%
Change (1 year)
Categories
Earnings for Akebia Therapeutics (AKBA)
Earnings in 2024 (TTM): -S$92.57 Million
According to Akebia Therapeutics's latest financial reports the company's current earnings are S$0.16 Billion. a decrease over its 2023 earnings that were of -S$69.54 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Akebia Therapeutics from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -S$92.96 Million | 33.68% |
| 2023 | -S$69.54 Million | -45.12% |
| 2022 | -S$0.13 Billion | -66.55% |
| 2021 | -S$0.38 Billion | -26.24% |
| 2020 | -S$0.52 Billion | 33.94% |
| 2019 | -S$0.39 Billion | 66.52% |
| 2018 | -S$0.24 Billion | 123.53% |
| 2017 | -S$0.11 Billion | -43.34% |
| 2016 | -S$0.19 Billion | 123.58% |
| 2015 | -S$81.32 Million | 63.95% |
| 2014 | -S$49.6 Million | 181.24% |
| 2013 | -S$17.64 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$6.17 B | -6,740.25% | 🇺🇸 USA |
 | S$18.26 B | -19,751.35% | 🇨🇭 Switzerland |
 | S$23.35 B | -25,228.94% | 🇺🇸 USA |
 | -S$0.23 Billion | 142.49% | 🇺🇸 USA |